Profile data is unavailable for this security.
About the company
Tristel plc is a United Kingdom-based infection prevention company. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. It addresses pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
- Revenue in GBP (TTM)46.46m
- Net income in GBP6.64m
- Incorporated2003
- Employees265.00
- LocationTristel PLCLynx Business Park,Fordham RoadSNAILWELL CB8 7NYUnited KingdomGBR
- Phone+44 163 872 1500
- Fax+44 163 872 1911
- Websitehttps://tristel.com/hk-en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aoti Inc | 47.22m | 1.74m | 44.01m | 80.00 | 20.75 | 3.35 | 12.68 | 0.932 | 0.0199 | 0.0199 | 0.4744 | 0.1234 | 1.32 | 2.17 | 4.65 | -- | 4.87 | -- | 6.54 | -- | 88.13 | -- | 3.69 | -- | 2.54 | 2.81 | 0.5269 | -- | 32.88 | -- | 78.55 | -- | -- | -- |
| Ondine Biomedical Inc | 1.19m | -12.89m | 46.92m | 43.00 | -- | 102.52 | -- | 39.50 | -0.0354 | -0.0354 | 0.0032 | 0.0009 | 0.3447 | 0.5771 | 8.03 | -- | -373.83 | -- | -4,807.85 | -- | 65.77 | -- | -1,084.66 | -- | 0.7948 | -- | 0.4333 | -- | 70.32 | -- | -32.51 | -- | -- | -- |
| Inspecs Group PLC | 192.83m | -3.31m | 69.64m | 1.65k | -- | 0.7816 | 7.46 | 0.3612 | -0.0326 | -0.0806 | 1.90 | 0.8764 | 0.9138 | 2.31 | 7.71 | 116,586.50 | -1.57 | -2.16 | -2.31 | -3.13 | 51.86 | 49.60 | -1.72 | -2.79 | 0.8847 | 1.73 | 0.3969 | -- | -2.48 | 32.80 | -362.19 | -- | 4.97 | -- |
| Creo Medical Group PLC | 2.20m | 12.60m | 72.18m | 133.00 | 5.92 | 1.19 | 5.19 | 32.81 | 0.0296 | 0.0272 | 0.0056 | 0.1477 | 0.0319 | -0.8034 | 0.3308 | 16,541.35 | 18.25 | -29.25 | 20.62 | -35.89 | 45.45 | 47.22 | 572.73 | -176.82 | 4.75 | -69.50 | 0.0645 | -- | 0.00 | 212.28 | -17.30 | -- | -18.58 | -- |
| SDI Group PLC | 69.29m | 4.59m | 85.75m | 504.00 | 19.07 | 1.67 | 9.46 | 1.24 | 0.043 | 0.043 | 0.6497 | 0.4923 | 0.7692 | -- | 5.78 | 137,484.10 | 5.12 | 7.08 | 5.81 | 8.87 | -- | 63.93 | 6.65 | 8.60 | 1.19 | 5.75 | 0.3363 | 0.00 | 0.5027 | 21.99 | -5.84 | 8.99 | 11.55 | -- |
| EKF Diagnostics Holdings PLC | 50.22m | 6.12m | 106.26m | 297.00 | 18.22 | 1.54 | 9.67 | 2.12 | 0.0135 | 0.0135 | 0.1109 | 0.1597 | 0.6209 | 3.16 | 7.34 | 165,745.90 | 7.98 | 5.79 | 8.77 | 6.76 | 49.79 | 49.42 | 12.86 | 8.62 | 3.47 | -- | 0.0152 | -- | -4.59 | 2.25 | 165.39 | 11.16 | 3.02 | -- |
| Tristel Plc | 46.46m | 6.64m | 200.97m | 265.00 | 30.37 | 6.07 | 21.29 | 4.33 | 0.1383 | 0.1383 | 0.9676 | 0.6915 | 1.04 | 1.93 | 5.81 | 175,328.30 | 14.85 | 9.60 | 17.57 | 11.09 | 80.62 | 80.90 | 14.29 | 11.04 | 2.96 | -- | 0.1512 | 120.71 | 10.80 | 7.96 | 2.33 | 5.42 | -3.59 | 18.10 |
| Advanced Medical Solutions Group plc | 220.30m | 9.12m | 477.60m | 1.50k | 52.17 | 1.86 | 15.71 | 2.17 | 0.0417 | 0.0417 | 1.01 | 1.17 | 0.5758 | 2.09 | 5.57 | 137,690.00 | 2.38 | 5.09 | 2.63 | 5.52 | 52.19 | 55.06 | 4.14 | 11.15 | 1.55 | 3.88 | 0.2428 | 33.47 | 40.66 | 11.64 | -55.35 | -17.81 | 8.36 | 10.90 |
| Holder | Shares | % Held |
|---|---|---|
| Liontrust Investment Partners LLPas of 02 Jul 2025 | 4.74m | 9.92% |
| Raymond James Wealth Management Ltd. (Investment Management)as of 30 Jun 2025 | 3.69m | 7.74% |
| Unicorn Asset Management Ltd.as of 31 Oct 2025 | 2.51m | 5.25% |
| BGF Investment Management Ltd.as of 30 Jun 2025 | 2.20m | 4.60% |
| Interactive Investor Services Ltd.as of 30 Jun 2025 | 2.17m | 4.54% |
| Montanaro Asset Management Ltd.as of 10 Nov 2025 | 1.86m | 3.89% |
| Rathbones Investment Management Ltd.as of 30 Jun 2025 | 1.73m | 3.61% |
| Danske Bank A/S (Investment Management)as of 28 May 2025 | 1.42m | 2.98% |
| Allianz Global Investors UK Ltd.as of 30 Jun 2023 | 1.42m | 2.97% |
| KW Investment Management Ltd.as of 01 Dec 2025 | 908.00k | 1.90% |
